2 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Recruiting 2, Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Respiratory Function Tests: new trials by email Literature Review of Respiratory Function Tests trials Research Report on Respiratory Function Tests
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Xe MRI to Guide Radiation Therapy for Lung Cancer Xenon MRI, Pulmonary Function Testing, Quality of Life Questionnaire - Imaging Techniques | Phase 2 | Recruiting | Sean Fain | 15 | 2025-08-30 | 2026-01-02 |
| Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology Hyperpolarized xenon 129, Cardiopulmonary Stress Test, Pulmonary Function Test - Electronic Cigarette Related Lung Damage | Phase 2 / Phase 3 | Recruiting | Y. Michael Shim, MD | 80 | 2024-12-19 | 2026-03-17 |
| Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Ibrutinib, ECG, PFT's - Chronic GVHD | Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2021-05-10 | 2026-01-23 |
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2018-09-04 | 2026-03-17 |
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population busulfan, respiratory function tests, pharmacokinetics, done during the treatment - Signs and Symptoms, Respiratory | Phase 2 | Unknown | University Hospital, Strasbourg, France | 35 | 2006-07-01 | 2009-02-25 |
Autoimmune Diseases (1) · Bronchiolitis Obliterans Syndrome (1) · Carcinoma in Situ (1) · Common Variable Immunodeficiency (1) · Hematologic Neoplasms (1) · Immune System Diseases (1) · Lung Neoplasms (1) · Lymphoproliferative Disorders (1) · Opportunistic Infections (1) · Papillomavirus Infections (1) · Signs and Symptoms, Respiratory (1) · T cell immunodeficiency primary (1) · Uterine Cervical Dysplasia (1) · Vaping (1) · Vulvar Diseases (1)
National Cancer Institute (NCI) (3) · Sean Fain (1) · University Hospital, Strasbourg, France (1) · Y. Michael Shim, MD (1)
United States (5) · France (1)
Dimana Dimitrova, M.D. (1) · Patrick Lutz, MD (1) · Scott M Norberg, D.O. (1) · Sean Fain, PhD (1) · Steven Z Pavletic, M.D. (1) · Yun M Shim, MD (1)